File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group

TitleADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
Authors
Cortese, SAsherson, PSonuga-Barke, EBanaschewski, TBrandeis, DBuitelaar, JCoghill, DDaley, DDanckaerts, MDittmann, RWDoepfner, MFerrin, MHollis, CHoltmann, MKonofal, ELecendreux, MSantosh, PRothenberger, ASoutullo, CSteinhausen, HCTaylor, EVan der Oord, SWong, IZuddas, ASimonoff, E
Keywordsanalgesia
attention deficit disorder
causal attribution
coronavirus disease 2019
drug effect
Issue Date2020
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.thelancet.com/journals/lanchi/issue/current
Citation
The Lancet Child & Adolescent Health, 2020, v. 4 n. 6, p. 412-414 How to Cite?
DOI: http://dx.doi.org/10.1016/S2352-4642(20)30110-3
DescriptionFor the European ADHD Guidelines Group
Persistent Identifierhttp://hdl.handle.net/10722/284937
ISSN
2352-4642
2023 Impact Factor: 19.9
2023 SCImago Journal Rankings: 4.229
PubMed Central ID
PMC7164889
ISI Accession Number ID
WOS:000536732100010

 

DC FieldValueLanguage
dc.contributor.authorCortese, S-
dc.contributor.authorAsherson, P-
dc.contributor.authorSonuga-Barke, E-
dc.contributor.authorBanaschewski, T-
dc.contributor.authorBrandeis, D-
dc.contributor.authorBuitelaar, J-
dc.contributor.authorCoghill, D-
dc.contributor.authorDaley, D-
dc.contributor.authorDanckaerts, M-
dc.contributor.authorDittmann, RW-
dc.contributor.authorDoepfner, M-
dc.contributor.authorFerrin, M-
dc.contributor.authorHollis, C-
dc.contributor.authorHoltmann, M-
dc.contributor.authorKonofal, E-
dc.contributor.authorLecendreux, M-
dc.contributor.authorSantosh, P-
dc.contributor.authorRothenberger, A-
dc.contributor.authorSoutullo, C-
dc.contributor.authorSteinhausen, HC-
dc.contributor.authorTaylor, E-
dc.contributor.authorVan der Oord, S-
dc.contributor.authorWong, I-
dc.contributor.authorZuddas, A-
dc.contributor.authorSimonoff, E-
dc.date.accessioned2020-08-07T09:04:35Z-
dc.date.available2020-08-07T09:04:35Z-
dc.date.issued2020-
dc.identifier.citationThe Lancet Child & Adolescent Health, 2020, v. 4 n. 6, p. 412-414-
dc.identifier.issn2352-4642-
dc.identifier.urihttp://hdl.handle.net/10722/284937-
dc.descriptionFor the European ADHD Guidelines Group-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.thelancet.com/journals/lanchi/issue/current-
dc.relation.ispartofThe Lancet Child & Adolescent Health-
dc.subjectanalgesia-
dc.subjectattention deficit disorder-
dc.subjectcausal attribution-
dc.subjectcoronavirus disease 2019-
dc.subjectdrug effect-
dc.titleADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group-
dc.typeArticle-
dc.identifier.emailWong, I: wongick@hku.hk-
dc.identifier.authorityWong, I=rp01480-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/S2352-4642(20)30110-3-
dc.identifier.pmid32311314-
dc.identifier.pmcidPMC7164889-
dc.identifier.scopuseid_2-s2.0-85083486928-
dc.identifier.hkuros311743-
dc.identifier.volume4-
dc.identifier.issue6-
dc.identifier.spage412-
dc.identifier.epage414-
dc.identifier.isiWOS:000536732100010-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl2352-4642-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats